+499.5%
MRNA vs KTOS
-25.6%
+525.1%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | KTOS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -0.6% | -1.6% | -2.1% |
| 7D | +5.5% | -8.0% | +13.5% | +7.1% |
| 30D | +158.7% | -13.6% | +172.3% | +164.7% |
| 3M | +182.1% | -24.6% | +206.7% | +194.9% |
| 6M | +151.8% | -46.3% | +198.2% | +175.7% |
| YTD | +393.6% | -37.0% | +430.6% | +405.1% |
| 1Y | +499.5% | -24.8% | +524.3% | +487.3% |
| All | +499.5% | -25.6% | +525.1% | +487.3% |
Cumulative growth
Daily Returns
Daily percentage return beside KTOS.
Daily Out/Under-Performance
Portfolio return minus KTOS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × KTOS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded KTOS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling